Sweden's Karo Snaps Up LEO's OTC Derma Brands
Karo Pharma will pay LEO Pharma €90m for a basket of dermatology and anti-hemorrhoid brands to expand its European footprint.
You may also be interested in...
Bayer follows through on plans to divest Dr. Scholl’s after selling Coppertone business in May to focus on consumer lines such as Aleve oral analgesics, Claritin allergy treatments and Bayer Aspirin. Private equity firm Yellow Wood Partners creating stand-alone company to operate Dr. Scholl's.
Karo’s new private-equity owners have flexed their muscles to snap up Sweden’s Trimb in a move which will expand the company’s reach in the Nordics and beyond.
Online price of cough and cold OTCs up double-digits in past week, according to the UK's Office for National Statistics. Paracetamol and vitamin D among other popular health products to record price rises.